Expression and clinical role of TCTP in epithelial ovarian cancer

[1]  M. Kanter,et al.  The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables , 2014, Journal of Molecular Histology.

[2]  Yi Guo,et al.  CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. , 2014, Oncology reports.

[3]  N. Mehlmer,et al.  The effect of Translationally Controlled Tumour Protein (TCTP) on programmed cell death in plants , 2013, BMC Plant Biology.

[4]  Kyunglim Lee,et al.  Immunohistochemical localization of translationally controlled tumor protein in the mouse digestive system , 2013, Journal of anatomy.

[5]  H. Danielsen,et al.  TCTP Is an Androgen-Regulated Gene Implicated in Prostate Cancer , 2013, PloS one.

[6]  T. Zhao,et al.  TCTP overexpression is associated with the development and progression of glioma , 2013, Tumor Biology.

[7]  Ping Yang,et al.  Lycorine hydrochloride selectively inhibits human ovarian cancer cell proliferation and tumor neovascularization with very low toxicity. , 2013, Toxicology letters.

[8]  M. Gleave,et al.  Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  S. Macdonald.  Potential role of histamine releasing factor (HRF) as a therapeutic target for treating asthma and allergy , 2012, Journal of asthma and allergy.

[10]  S. Ichikawa,et al.  Biological Effects of Mammalian Translationally Controlled Tumor Protein (TCTP) on Cell Death, Proliferation, and Tumorigenesis , 2012, Biochemistry research international.

[11]  Magdalena J Koziol,et al.  TCTP in Development and Cancer , 2012, Biochemistry research international.

[12]  S. Rho,et al.  Anti‐apoptotic protein TCTP controls the stability of the tumor suppressor p53 , 2011, FEBS letters.

[13]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[14]  M. Gnanasekar,et al.  Translationally controlled tumor protein is a novel heat shock protein with chaperone-like activity. , 2009, Biochemical and biophysical research communications.

[15]  E. Ioachim.  Expression patterns of cyclins D1, E and cyclin‐dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki‐67 and PCNA) and clinicopathological features , 2008, International journal of clinical practice.

[16]  A. Phongdara,et al.  Fortilin binds Ca2+ and blocks Ca2+-dependent apoptosis in vivo. , 2007, The Biochemical journal.

[17]  Kwang-Wook Choi,et al.  To Cease or To Proliferate , 2007, Cell adhesion & migration.

[18]  Bin Wen,et al.  Comparative Proteome Analysis of Breast Cancer and Adjacent Normal Breast Tissues in Human , 2006, Genom. Proteom. Bioinform..

[19]  H. Yang-Yen,et al.  Stabilization and Enhancement of the Antiapoptotic Activity of Mcl-1 by TCTP , 2005, Molecular and Cellular Biology.

[20]  E. Neuwelt,et al.  The Chemoprotective Agent N-Acetylcysteine Blocks Cisplatin-Induced Apoptosis through Caspase Signaling Pathway , 2005, Journal of Pharmacology and Experimental Therapeutics.

[21]  J. Langdon,et al.  Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta). , 2004, Biochimica et biophysica acta.

[22]  S. Prieur,et al.  Biological models and genes of tumor reversion: Cellular reprogramming through tpt1/TCTP and SIAH-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Weidner,et al.  Physical and Functional Interaction between Myeloid Cell Leukemia 1 Protein (MCL1) and Fortilin , 2002, The Journal of Biological Chemistry.

[24]  Kyunglim Lee,et al.  Expression of translationally controlled tumor protein mRNA in human colon cancer. , 2000, Cancer letters.

[25]  T. Rafnar,et al.  Molecular identification of an IgE-dependent histamine-releasing factor. , 1995, Science.

[26]  G. Brawerman,et al.  Nucleotide sequence for a major messenger RNA for a 40 kilodalton polypeptide that is under translational control in mouse tumor cells. , 1988, Nucleic acids research.

[27]  H. Kajiyama,et al.  Spectrin αII and βII tetramers contribute to platinum anticancer drug resistance in ovarian serous adenocarcinoma , 2012, International journal of cancer.

[28]  Ming Li,et al.  The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. , 2010, Journal of proteome research.

[29]  G. Brawerman,et al.  Nucleotide sequence of a major messenger RNA for a 21 kilodalton polypeptide that is under translational control in mouse tumor cells. , 1988, Nucleic acids research.